ING Groep NV Sells 23,441 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

ING Groep NV lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 74.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,237 shares of the company’s stock after selling 23,441 shares during the period. ING Groep NV’s holdings in GE HealthCare Technologies were worth $644,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. LGT Financial Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares in the last quarter. Ashton Thomas Securities LLC acquired a new stake in GE HealthCare Technologies during the 3rd quarter worth $26,000. Capital Performance Advisors LLP acquired a new stake in GE HealthCare Technologies during the 3rd quarter worth $26,000. Darwin Wealth Management LLC acquired a new stake in GE HealthCare Technologies during the 3rd quarter worth $31,000. Finally, Continuum Advisory LLC grew its holdings in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after acquiring an additional 168 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Citigroup lifted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Wells Fargo & Company lifted their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Trading Down 0.6 %

GEHC opened at $90.57 on Tuesday. The stock has a market capitalization of $41.42 billion, a P/E ratio of 20.92, a P/E/G ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80. The firm’s fifty day simple moving average is $85.26 and its 200 day simple moving average is $85.96. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.